| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |